EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Proteomic Heterogeneity Beyond Glycemia Status in Severe Obesity

Melissa M Milito iD, Mattia Chiesa iD, Alice Mallia iD, Giulia G Papaianni iD, Julia T Regalado iD, Claudio Tiribelli iD, Deborah Bonazza, Natalia Rosso iD, Silvia Palmisano iD, Cristina Banfi iD, Pablo J Giraudi iD

International Journal of Molecular Sciences · 06.05.2026 · 27 (9) · 4152

DOI: 10.3390/ijms27094152 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.05.2026. Verfasst von Melissa M Milito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Liver Disease Unit, Fondazione Italiana Fegato, 34012 Trieste, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Proteomics, Inflammation, Obesity, Morbid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Italian Ministry of Health, Italian Liver Foundation NPO.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic low-grade inflammation is a key feature of obesity-associated dysglycemia, yet substantial heterogeneity exists in inflammatory responses among individuals with normoglycemia, prediabetes, and type 2 diabetes mellitus (T2DM). Whether circulating inflammatory protein profiles define distinct patient phenotypes beyond conventional glycemic classification remains incompletely understood. In this cross-sectional analysis of 142 individuals with severe obesity, plasma inflammatory proteins were quantified using Olink proximity extension assay technology. Subjects were stratified by glycemic status (noDM, normoglycemia; PreDM, prediabetes and T2DM) while maintaining comparable distributions of metabolic dysfunction-associated steatotic liver disease. Differential expression analyses were performed across glycemic groups, and unsupervised topological data analysis (TDA) was applied to identify inflammatory protein-based patient subgroups. Several inflammatory proteins were significantly upregulated in T2DM and PreDM compared with noDM, with interleukin-8 (IL-8), Fms-relatedlike tyrosine kinase 3 ligand (Flt3L), and CUB domain containing protein (CDCP1) showing the largest significant differences. NPX distributions of these proteins exhibited gradual increases across glycemic stages with substantial inter-individual variability. TDA identified seven clusters defined by distinct inflammatory protein signatures. One cluster was enriched for individuals with T2DM and characterized by coordinated upregulation of IL-8, Flt3L, CDCP1, and additional immune- and cytokine-related proteins, whereas other clusters displayed alternative inflammatory profiles that were not explained by glycemic status alone. Inflammatory proteomic profiling in severe obesity reveals both glycemia-associated protein changes and distinct inflammatory phenotypes that transcend conventional clinical classification. Integration of differential expression analysis with TDA highlights heterogeneity in inflammatory states, supporting a hypothesis-generating framework for future studies aimed at validating these proteomic patterns and clarifying their longitudinal relevance in obesity-related dysglycemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2ProteomicsInflammationObesity, MorbidBlood GlucoseProteomeHumansFemaleMaleMiddle AgedCross-Sectional StudiesAdultPrediabetic StateBiomarkers

Stichwörter der Autor:innen

immune phenotypesinflammatory proteomicslow-grade inflammationtopological data analysistype 2 diabetes

Substanzen

Blood GlucoseProteomeBiomarkers

Autor:innen und Institutionen

  • Metabolic Liver Disease Unit, Fondazione Italiana Fegato, 34012 Trieste, Italy.
  • Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
  • Bioinformatics and Artificial Intelligence Facility, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
  • Unit of Functional Proteomics, Metabolomics, and Network Analysis, Centro Cardiologico Monzino IRCCS, 20138 Milan, Italy.
  • Department of Science and Technology, Philippine Council for Health Research and Development, Bicutan, Taguig 1631, Philippines.
  • Surgical Pathology Unit, Cattinara Hospital, Azienda Sanitaria Universitaria Giuliano Isontina, 34149 Trieste, Italy.

ORCID-Profile: Melissa M Milito, Mattia Chiesa, Alice Mallia, Giulia G Papaianni, Julia T Regalado, Claudio Tiribelli, Natalia Rosso, Silvia Palmisano, Cristina Banfi, Pablo J Giraudi

Förderung

  • European Union
  • Italian Ministry of Health
  • Italian Liver Foundation NPO
  • Department of Life Sciences of the University of Trieste, UNITS
  • Department of Science and Technology—Philippine Council for Health Research and Development

Zitieren

APA

Milito, M. M., Chiesa, M., Mallia, A., Papaianni, G. G., Regalado, J. T., Tiribelli, C., Bonazza, D., Rosso, N., Palmisano, S., Banfi, C., & Giraudi, P. J. (2026). Inflammatory Proteomic Heterogeneity Beyond Glycemia Status in Severe Obesity. International Journal of Molecular Sciences, 27(9), 4152. https://doi.org/10.3390/ijms27094152

Vancouver

Milito MM, Chiesa M, Mallia A, Papaianni GG, Regalado JT, Tiribelli C, et al. Inflammatory Proteomic Heterogeneity Beyond Glycemia Status in Severe Obesity. International Journal of Molecular Sciences. 2026;27(9):4152. doi:10.3390/ijms27094152

BibTeX
@article{Milito2026,
  author = {Milito, Melissa M and Chiesa, Mattia and Mallia, Alice and Papaianni, Giulia G and Regalado, Julia T and Tiribelli, Claudio and Bonazza, Deborah and Rosso, Natalia and Palmisano, Silvia and Banfi, Cristina and Giraudi, Pablo J},
  title = {Inflammatory Proteomic Heterogeneity Beyond Glycemia Status in Severe Obesity},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {9},
  pages = {4152},
  doi = {10.3390/ijms27094152}
}
Kostenlos starten →